Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.770 HKD | +1.65% |
|
-2.73% | +23.54% |
03-28 | Fufeng Group Limited Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
03-06 | Fufeng Unit Settles Dispute for Xanthan Gum Production Secrecy | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 16.69B | 21.54B | 27.47B | 28.01B | 27.76B | |||||
Total Revenues | 16.69B | 21.54B | 27.47B | 28.01B | 27.76B | |||||
Cost of Goods Sold, Total | 13.87B | 17.63B | 20.26B | 21.76B | 22.7B | |||||
Gross Profit | 2.82B | 3.91B | 7.21B | 6.25B | 5.06B | |||||
Selling General & Admin Expenses, Total | 2.2B | 2.35B | 2.81B | 3.01B | 3.05B | |||||
Provision for Bad Debts | - | 16.71M | -11.16M | 2.45M | -7.17M | |||||
Other Operating Expenses | -276M | -136M | -372M | -139M | -334M | |||||
Other Operating Expenses, Total | 1.93B | 2.23B | 2.43B | 2.87B | 2.71B | |||||
Operating Income | 891M | 1.67B | 4.79B | 3.38B | 2.34B | |||||
Interest Expense, Total | -206M | -173M | -239M | -165M | -204M | |||||
Interest And Investment Income | 43.65M | 36.27M | 101M | 331M | 499M | |||||
Net Interest Expenses | -162M | -136M | -138M | 165M | 295M | |||||
Income (Loss) On Equity Invest. | -9.37M | -10.22M | -1.27M | -194K | -114K | |||||
Currency Exchange Gains (Loss) | 68.82M | 39.39M | 232M | 146M | 197M | |||||
Other Non Operating Income (Expenses) | - | -50M | - | - | - | |||||
EBT, Excl. Unusual Items | 788M | 1.52B | 4.88B | 3.69B | 2.84B | |||||
Gain (Loss) On Sale Of Investments | -11.34M | - | -7.48M | - | -4.77M | |||||
Gain (Loss) On Sale Of Assets | -6.22M | -1.59M | -11.53M | 161M | -8.55M | |||||
Asset Writedown | - | - | - | - | - | |||||
Insurance Settlements | - | - | - | - | - | |||||
Legal Settlements | - | - | - | - | 15M | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 771M | 1.52B | 4.86B | 3.85B | 2.84B | |||||
Income Tax Expense | 141M | 235M | 999M | 706M | 525M | |||||
Earnings From Continuing Operations | 630M | 1.28B | 3.86B | 3.14B | 2.31B | |||||
Net Income to Company | 630M | 1.28B | 3.86B | 3.14B | 2.31B | |||||
Net Income - (IS) | 630M | 1.28B | 3.86B | 3.14B | 2.31B | |||||
Net Income to Common Incl Extra Items | 630M | 1.28B | 3.86B | 3.14B | 2.31B | |||||
Net Income to Common Excl. Extra Items | 630M | 1.28B | 3.86B | 3.14B | 2.31B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.25 | 0.51 | 1.52 | 1.24 | 0.92 | |||||
Basic EPS - Continuing Operations | 0.25 | 0.51 | 1.52 | 1.24 | 0.92 | |||||
Basic Weighted Average Shares Outstanding | 2.53B | 2.53B | 2.53B | 2.54B | 2.52B | |||||
Net EPS - Diluted | 0.25 | 0.51 | 1.52 | 1.24 | 0.92 | |||||
Diluted EPS - Continuing Operations | 0.25 | 0.51 | 1.52 | 1.24 | 0.92 | |||||
Diluted Weighted Average Shares Outstanding | 2.53B | 2.53B | 2.54B | 2.54B | 2.52B | |||||
Normalized Basic EPS | 0.19 | 0.37 | 1.2 | 0.91 | 0.7 | |||||
Normalized Diluted EPS | 0.19 | 0.37 | 1.2 | 0.91 | 0.7 | |||||
Dividend Per Share | 0.09 | 0.18 | 0.53 | 0.41 | 0.32 | |||||
Payout Ratio | 50.34 | 22.85 | 27.95 | 40.85 | 52.71 | |||||
American Depositary Receipts Ratio (ADR) | 20 | 20 | 20 | 20 | 20 | |||||
Supplemental Items | ||||||||||
EBITDA | 2.12B | 2.89B | 5.92B | 4.47B | 3.53B | |||||
EBITA | 891M | 1.68B | 4.79B | 3.38B | 2.35B | |||||
EBIT | 891M | 1.67B | 4.79B | 3.38B | 2.34B | |||||
EBITDAR | 2.13B | 2.9B | 5.93B | 4.49B | 3.55B | |||||
Effective Tax Rate - (Ratio) | 18.26 | 15.52 | 20.56 | 18.34 | 18.49 | |||||
Current Domestic Taxes | 131M | 230M | 859M | 618M | 454M | |||||
Current Foreign Taxes | 162K | - | - | 54.92M | 30.86M | |||||
Total Current Taxes | 131M | 230M | 859M | 673M | 485M | |||||
Total Deferred Taxes | 9.28M | 5.78M | 141M | 33.43M | 40.04M | |||||
Normalized Net Income | 493M | 948M | 3.05B | 2.31B | 1.77B | |||||
Interest Capitalized | - | - | - | - | - | |||||
Interest on Long-Term Debt | 117M | 69.49M | 71K | 51K | 42K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 12.51M | 13.49M | 10.58M | 8.76M | - | |||||
Selling and Marketing Expenses | 1.38B | 1.4B | 1.76B | 1.8B | 1.96B | |||||
General and Administrative Expenses | 806M | 939M | 1.04B | 1.19B | 1.07B | |||||
Research And Development Expense From Footnotes | 325M | 387M | 382M | 375M | 366M | |||||
Net Rental Expense, Total | 10.36M | 9.8M | 12.13M | 14.02M | 21.68M | |||||
Imputed Operating Lease Interest Expense | 4.89M | 3.45M | 4.48M | 2.34M | 3.34M | |||||
Imputed Operating Lease Depreciation | 5.47M | 6.34M | 7.65M | 11.68M | 18.34M | |||||
Stock-Based Comp., Other (Total) | -1.87M | -2.4M | 785K | 1.08M | 1.02M | |||||
Total Stock-Based Compensation | -1.87M | -2.4M | 785K | 1.08M | 1.02M |
- Stock Market
- Equities
- 546 Stock
- Financials Fufeng Group Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition